166 related articles for article (PubMed ID: 18007558)
1. Long-term outcome after interferon therapy in patients with chronic hepatitis C.
Buti M; Esteban R
Ann Hepatol; 2007; 6(4):267-9. PubMed ID: 18007558
[No Abstract] [Full Text] [Related]
2. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
Nishiguchi S; Kubo S; Shiomi S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
[No Abstract] [Full Text] [Related]
3. [Chronic hepatitis C: what to do if the first treatment failed?].
Asselah T
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B50-9. PubMed ID: 12180309
[No Abstract] [Full Text] [Related]
4. [Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related chronic hepatitis and cirrhosis].
Kasahara A; Hiramatsu N
Nihon Rinsho; 2011 May; 69 Suppl 4():314-8. PubMed ID: 22096937
[No Abstract] [Full Text] [Related]
5. [Histological findings in the liver in patients with chronic hepatitis C].
Takase K; Shiraki K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
[No Abstract] [Full Text] [Related]
6. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C and interferon: fewer cases of liver cancer.
Prescrire Int; 2013 Jul; 22(140):191. PubMed ID: 23951600
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of hepatocellular carcinogenesis by interferon].
Ikeda K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
[No Abstract] [Full Text] [Related]
9. [Treatment of hepatitis C virus-related cirrhosis].
Bronowicki JP
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
[No Abstract] [Full Text] [Related]
10. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
Lengyel G; Fehér J
Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786
[TBL] [Abstract][Full Text] [Related]
11. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of response to treatment in chronic hepatitis C].
Leroy V; Hilleret MN
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B23-31. PubMed ID: 12180294
[No Abstract] [Full Text] [Related]
13. [Hepatitis C and liver transplantation].
Durand F
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
[No Abstract] [Full Text] [Related]
14. [Hepatocellular carcinogenesis and prognosis of elderly patients with chronic hepatitis type C].
Ikeda K; Arase Y; Kumada H
Nihon Rinsho; 2001 Jul; 59(7):1338-44. PubMed ID: 11494548
[TBL] [Abstract][Full Text] [Related]
15. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
Fukuda A
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
[No Abstract] [Full Text] [Related]
17. [Chronic hepatitis C virus infection: always treat!--Pro].
Zeuzem S
Dtsch Med Wochenschr; 2002 Sep; 127(36):1840. PubMed ID: 12215931
[No Abstract] [Full Text] [Related]
18. [Interferon therapy to chronic hepatitis type C for the prevention of hepatocarcinogenesis].
Ichida T; Ohkoshi S; Takimoto M; Ishikawa T
Nihon Rinsho; 2001 Jul; 59(7):1331-7. PubMed ID: 11494547
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatocellular carcinoma after sustained response to interferon therapy: how long should sustained responders with risk factors be followed?
Kasahara A
J Gastroenterol; 2005 Feb; 40(2):220-2. PubMed ID: 15770412
[No Abstract] [Full Text] [Related]
20. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
